摘要 |
<p>It is intended to provide a method of screening a candidate drug mainly metabolized by a drug metabolizing enzyme, CYP2D6, CYP2C9 or CYP2C19 with the use of a chimeric mouse carrying human hepatocytes transplanted thereinto, whereby it is determined whether or not the candidate drug is metabolized in a subject deficient in CYP2D6, CYP2C9 or CYP2C19. It is also intended to provide a method of determining whether or not a candidate drug induces or inhibits the activity of any of drug metabolizing enzymes, CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 with the use of a chimeric mouse carrying human hepatocytes transplanted thereinto.</p> |
申请人 |
HIROSHIMA INDUSTRIAL PROMOTION ORGANIZATION;BIOINTEGRENCE INC.;PHOENIXBIO CO., LTD.;SUMIKA CHEMICAL ANALYSIS SERVICE, LIMITED |
发明人 |
MUKAIDANI, CHISE;YOSHIZATO, KATSUTOSHI;NISHIKURA, YASUFUMI;HORIE, TORU;NAKAZAWA, HIROSHI;KANAMARU, HIROSHI;UEDA, CHIAKI;HINE, CHIEMI |